您当前的位置:
首页 >
文章列表页 >
Anti-hepatocarcinoma HepG2 Cell Mechanism of Jaranol: Based on PI3K/Akt Signaling Pathway
更新时间:2023-05-17
    • Anti-hepatocarcinoma HepG2 Cell Mechanism of Jaranol: Based on PI3K/Akt Signaling Pathway

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 28, Issue 9, Pages: 80-87(2022)
    • DOI:10.13422/j.cnki.syfjx.20220799    

      CLC: R933/937;R289;R22;R2-031;R282
    • Received:14 April 2021

      Published Online:01 March 2022

      Published:05 May 2022

    移动端阅览

  • YAO Hong,HOU Yu-xin,REN Jin-hong,et al.Anti-hepatocarcinoma HepG2 Cell Mechanism of Jaranol: Based on PI3K/Akt Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(09):80-87. DOI: 10.13422/j.cnki.syfjx.20220799.

  •  
  •  

0

Views

22

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect of Stemona tuberosa Alkaloids on Apoptosis and PI3K/Akt and JNK/MAPK Signaling Pathways of Human Lung Cancer A549 Cells
Apigenin Induces Apoptosis of Human Colorectal Cancer CL187 Cells via PI3K/Akt and MAPK Signaling Pathways
Effect of Cantharidin on Growth, Survival and Mechanism in HepG2 Cells
Effect of Hawthorn Extract on Apoptosis and Related Factors of HepG2 Cells
Treatment of Sepsis-induced Inflammatory Responses with Xijiao Dihuangtang by Modulation of PKM2-mediated One-carbon Metabolism Pathway

Related Author

LIN Si
QIN Huizhen
LI Zeyu
XU Liba
DENG Lingyu
LUO Jing
XIE Fengfeng
ZHANG Miao

Related Institution

Guangxi University of Chinese Medicine
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Guangxi University of Chinese Medicine
Affiliated Hospital of Nanjing University of Chinese Medicine
The First Clinical Medical College,Nanjing University of Chinese Medicine
Jiangsu Province Hospital of Chinese Medicine
0